Clinical Trial

Influence of Hydration Status on the Yield of Injectable Platelet-Rich Fibrin

Study acronym: T-PRF
Completed
View on ClinicalTrials.gov →
Summary
Due to the current lack of evidence regarding the influence of fluid intake on the amount of leukocyte- and platelet-rich fibrin fraction present in blood samples, this study aims to investigate the positive influence of this factor on the body's own matrix. Platelet-rich fibrin, a fibrin-rich autologous matrix obtained from autologous blood via centrifugation, contains not only fibrin but also important growth factors and a large number of white blood cells, all of which make a significant contribution to tissue regeneration. The obtained fibrin matrix can be used as a membrane, as a clot (A-PRF), or as a liquid (i-PRF) to positively influence the healing process. The novelty of this work lies in shifting the focus from purely technical centrifugation parameters to a patient-centered, easily modifiable biological variable. Hydration status represents a low-cost, non-invasive, and immediately applicable strategy to optimize autologous blood concentrates. These findings are directly relevant to clinicians seeking to enhance the predictability and efficiency of PRF-based regenerative procedures in implant dentistry.
Trial Details
NCT Number NCT07506252
Lead Sponsor Medical University of Graz
Conditions PRF, Behavior Change Interventions, Implant Dentistry
Enrollment 26 participants
Start Date 2022-12-12
Primary Completion 2023-05-19 (estimated)
Study Completion 2023-05-19 (estimated)
Updated on ClinicalTrials.gov 2026-04-01